Novel Inhibitor of human immunodeficiency virus type 1 (HIV-1) attachment

Prodrug of the novel fluoro-substituted camptothecin analog, BMS-286309

Novel Selective CYP17A1 Lyase Inhibitor

Novel dissociated glucocorticoid receptor modulator

Novel fluoro-substituted camptothecin, inducing topoisomerase I-mediated DNA breaks

Highly potent and selective phosphodiesterase 5 (PDE 5) inhibitor

Potent and selective beta-lactam tryptase inhibitor, inhibiting factor XIa and producing antithrombotic efficacy with minimal bleeding time prolongation

Selective ATP hydrolase inhibitor

Potent and selective p56(lck) inhibitor

Potent and selective β3 full agonist

Novel potent inhibitor of the ATP hydrolase activity of mitochondrial F1F0 ATP synthase

Novel and selective neuropeptide Y1 receptor antagonist

Retinoic acid receptor (RAR) pan-antagonist

Squalene synthase inhibitor

Quantity (mg or Unit) Unit Price ($/mg or $/Unit) Final Price 100 $13.95 Total: $1,395.00 50 $16.12 Total: $806.00 25 $18.91 Total: $472.75 10 $22.32 Total: $223.20 5 $26.35 Total: $131.75

Novel antifungal and fungicidal agent

Novel K channel opener; Glyburide-Reversible Cardioprotective Agent with Minimal Vasodilator Activity

5HT1B/1D agonist

Novel potent, selective inhibitor of AAK1 (adaptor associated kinase 1), having the appropriate combination of solubility and charge required for microiontophoresis

Novel PD-1/PD-L1 Inhibitor

Novel PD-L1 Inhibitor

Novel Highly Selective LRRK2 Inhibitor

Novel activator of BMP signaling, enhancing osteoblast differentiation, targeting HECT domain of ubiquitin ligase Smurf1, up-regulating the protein level of Smad1/5

Novel activator of BMP signaling, enhancing osteoblast differentiation, targeting HECT domain of ubiquitin ligase Smurf1, up-regulating the protein level of Smad1/5

Metabolite of BML277 which is a selective checkpoint kinase 2 inhibitor

Potent and selective inhibitor of Cdk5/p25, protecting large population of cells against non-A

Novel potent cyclin-dependent kinases (CDK) inhibitor, inducing a strong cell cycle alteration

Novel inhibitor of RNA polymerase I, causing nucleolar stress and showing potent anticancer activity across many tumor types

Novel LRP5/6-sclerostin interaction inhibitor, recovering the downregulated activity of the Wnt/β-catenin signaling pathway by competitive binding to the LRP5/6-sclerostin complex

Novel potent EGFR inhibitor